Roelof Rongen
2015
In 2015, Roelof Rongen earned a total compensation of $533.6K as Chief Executive Officer at Matinas BioPharma Holdings, a 14% decrease compared to previous year.
Compensation breakdown
| Bonus | $132,000 |
|---|---|
| Option Awards | $101,638 |
| Salary | $300,000 |
| Total | $533,638 |
Rongen received $300K in salary, accounting for 56% of the total pay in 2015.
Rongen also received $132K in bonus and $101.6K in option awards.
Rankings
In 2015, Roelof Rongen's compensation ranked 10,573rd out of 13,638 executives tracked by ExecPay. In other words, Rongen earned more than 22.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,573 out of 13,638 | 23rd |
Division Manufacturing | 4,033 out of 5,187 | 22nd |
Major group Chemicals And Allied Products | 1,486 out of 1,857 | 20th |
Industry group Drugs | 1,224 out of 1,531 | 20th |
Industry Pharmaceutical Preparations | 953 out of 1,179 | 19th |
Source: SEC filing on September 14, 2017.
Rongen's colleagues
We found three more compensation records of executives who worked with Roelof Rongen at Matinas BioPharma Holdings in 2015.